{
    "nctId": "NCT03795493",
    "briefTitle": "Diet Restriction and Exercise-induced Adaptations in Metastatic Breast Cancer",
    "officialTitle": "Diet Restriction and Exercise-induced Adaptations in Metastatic Breast Cancer",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 23,
    "primaryOutcomeMeasure": "Tumor size change after 6 cycles (mm)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of stage IV or metastatic breast cancer;\n* Measurable metastases.\n* Age \\>18\n* Starting (or having only received one treatment of) any type of intravenously administered chemotherapy;\n* Eastern Cooperative Oncology Group (ECOG) Score \\< 3\n* Oncologist approval to participate\n* Able to communicate and read and understand English;\n* Willing and able to adhere to the study interventions and assessments;\n\nExclusion Criteria:\n\n* Limitations to sustained exercise (including bone metastases in the femur neck);\n* Clinical evidence of cachexia (oncologist's discretion, study team will use body mass index \\<18.5kg/m\u00b2 as a flag to highlight concern to treating oncologist);\n* Body mass \\>109 kg at time of enrollment;\n* Diabetes;\n* Severe food allergies;\n* History of eating disorder (diagnosed or self-reported);\n* Strict diet restrictions including vegetarian or vegan;\n* Unable to provide informed consent (i.e. cognitive impairment);\n* Supplemental oxygen requirement;\n* Uncontrolled pleural effusions (oncologists approval if pleural effusions exists and are controlled);\n* Bilirubin \\>30 umol/L;\n* Creatinine \\>120 umol/L;\n* Pregnant;\n* Contraindications to 3T MRI for research purposes",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}